🔍
Hypoxia-inducible factor reporter cell lines
Case ID:
C15753
Report of Invention:
3/8/2019
Web Published:
10/9/2019
Unmet Need
Low oxygen levels are a characteristic of many types of solid tumors. High levels of HIF1α, the transcription factor responsible for energy utilization under hypoxic conditions, has been implicated in tumor growth and resistance, angiogenesis, and poor patient prognosis. For these reasons, HIF1α remains an attractive target for novel cancer therapeutics. The field currently lacks robust tools for high-throughput screening of candidate compounds to target this pathway.
Technology Overview
Researchers at Johns Hopkins have used a lentiviral construct to engineer multiple human HIF-1α reporter cell lines. These cell lines can be used to identify modulators of oxygen homeostasis, energy utilization, erythrogenesis, and cancer metabolism.
Stage of Development
The inventors have engineered human cell lines with a robust GFP reporter of HIF1α activity, and have validated their reporting capabilities using in vitro assays.
Publications
None at this time.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://jhu.technologypublisher.com/technology/36555
Inventors:
Category(s):
Technology Classifications > Research Tools > Cell Lines,
Get custom alerts for techs in these categories/from these inventors:
Subscribe for JHTV Updates
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
Bookmark this page
Download as PDF
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum